Fig. 8From: Engineered exosome-mediated delivery of circDIDO1 inhibits gastric cancer progression via regulation of MiR-1307-3p/SOCS2 AxisSchematic diagram shows that RGD-Exo-circDIDO1 inhibits GC progression through miR-1307-3p/SOSC2 axis. CircDIDO1 is delivered to GC cells by RGD-modified engineered exosomes. CircDIDO1 sponges miR-1307-3p to upregulate SOCS2 expression, thus inhibiting GC progressionBack to article page